ScoreWhy is Guangdong Biolight Meditech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -4.48% and Operating profit at -173.40% over the last 5 years
2
Flat results in Sep 25
- NET PROFIT(HY) At CNY -22.77 MM has Grown at -31.86%
- INTEREST(Q) At CNY 7.2 MM has Grown at 12.79%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 101.13%, its profits have risen by 56.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Guangdong Biolight Meditech Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Guangdong Biolight Meditech Co., Ltd.
101.13%
2.15
60.23%
China Shanghai Composite
16.01%
1.07
14.97%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.48%
EBIT Growth (5y)
-173.40%
EBIT to Interest (avg)
4.56
Debt to EBITDA (avg)
0.43
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.56
Tax Ratio
2.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.43%
ROE (avg)
8.54%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.83
EV to EBIT
-27.87
EV to EBITDA
-1276.22
EV to Capital Employed
1.76
EV to Sales
2.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.33%
ROE (Latest)
-4.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at CNY -22.77 MM
RAW MATERIAL COST(Y)
Fallen by -13.03% (YoY
DIVIDEND PER SHARE(HY)
Highest at CNY 3.66
-5What is not working for the Company
NET PROFIT(HY)
At CNY -22.77 MM has Grown at -31.86%
INTEREST(Q)
At CNY 7.2 MM has Grown at 12.79%
Here's what is working for Guangdong Biolight Meditech Co., Ltd.
Net Profit
Higher at CNY -22.77 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Dividend per share
Highest at CNY 3.66
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CNY)
Raw Material Cost
Fallen by -13.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Guangdong Biolight Meditech Co., Ltd.
Interest
At CNY 7.2 MM has Grown at 12.79%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Profit
At CNY -22.77 MM has Grown at -31.86%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
